Brief: Synlogic Granted Fast Track Designation From FDA For labafenogene marselecobac (SYNB1934) For Treatment Of Phenylketonuria

Synlogic

11/07/2023 12:36

July 11 (Reuters) - Synlogic Inc  SYBX.O :
    * SYNLOGIC GRANTED FAST TRACK DESIGNATION FROM FDA FOR
LABAFENOGENE MARSELECOBAC (SYNB1934) FOR TREATMENT OF
PHENYLKETONURIA
    * SYNLOGIC INC - LABAFENOGENE MARSELECOBAC HAS ALSO RECEIVED
RARE
DISEASE DESIGNATION, ORPHAN DRUG DESIGNATION BY FDA AND ORPHAN
DESIGNATION FROM EMA

Source text for Eikon:  ID:nGNXbtHrlg 
Further company coverage:  SYBX.O 

 ((reuters.briefs@thomsonreuters.com;))